Aller au contenu principal
Affichage de 1 à 10 sur 155
Zerbib L, Ladraa S, Fraissenon A, Bayard C, Firpion M, Venot Q, Protic S, Hoguin C, Thomas A, Fraitag S, Duong JP, Kaltenbach S, Balducci E, Lefevre C, Villarese P, Asnafi V, Broissand C, Goudin N, Nemazanyy I, Autret G, Tavitian B, Legendre C, Arzouk N, Minard-Colin V, Chopinet C, Dussiot M, Adams DM, Mirault T, Guibaud L, Isenring P, Canaud G. Targeted therapy for capillary-venous malformations. Signal Transduct Target Ther. 2024; Jun 17;9(1):146. doi: 10.1038/s41392-024-01862-9. PMID: 38880808; PMCID: PMC11180659.
Xiang Y, Mata-Garrido J, Fu Y, Desterke C, Batsché E, Hamaï A, Sedlik C, Sereme Y, Skurnik D, Jalil A, Onifarasoaniaina R, Frapy E, Beche JC, Alao R, Piaggio E, Arbibe L, Chang Y. CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity. EMBO Mol Med. 2024; Jun;16(6):1404-1426. doi: 10.1038/s44321-024-00066-6. PMID: 38684864; PMCID: PMC11178889.
Simonin M, Vasseur L, Lengliné E, Lhermitte L, Cabannes-Hamy A, Balsat M, Schmidt A, Dourthe ME, Touzart A, Graux C, Grardel N, Cayuela JM, Arnoux I, Gandemer V, Rigal-Huguet F, Ducassou S, Lheritier V, Chalandon Y, Ifrah N, Dombret H, Macintyre EA, Petit A, Rousselot P, Lambert J, Baruchel A, Boissel N, Asnafi V. NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients. Blood. 2024; Jun 7:blood.2023023754. Epub ahead of print. doi: 10.1182/blood.2023023754. PMID: 38848537.
Yamaguchi J, Isnard P, Robil N, de la Grange P, Hoguin C, Schmitt A, Hummel A, Mégret J, Goudin N, Luka M, Ménager MM, Masson C, Zarhrate M, Bôle-Feysot C, Janiszewska M, Polyak K, Dairou J, Baldassari S, Baulac S, Broissand C, Legendre C, Terzi F, Canaud G. PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis. J Clin Invest. 2024; Jun 6:e176402. Epub ahead of print. doi: 10.1172/JCI176402. PMID: 38842935.
Bardin E, Dietrich C, Attailia M, Ferroni A, Jamet A, Lezmi G, Sermet-Gaudelus I, Leite-de-Moraes M. Restored Cytokine-Producing Capacities of Mucosal-Associated Invariant T Cells in Pediatric Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor. Am J Respir Crit Care Med. 2024; May 17. Epub ahead of print. doi: 10.1164/rccm.202401-0201LE. PMID: 38760016.
Zhu S, Waeckel-Énée E, Oshima M, Moser A, Bessard MA, Gdoura A, Roger K, Mode N, Lipecka J, Yilmaz A, Bertocci B, Diana J, Saintpierre B, Guerrera IC, Scharfmann R, Francesconi S, Mauvais FX, van Endert P. Islet cell stress induced by insulin-degrading enzyme deficiency promotes regeneration and protection from autoimmune diabetes. iScience. 2024; May 7;27(6):109929. doi: 10.1016/j.isci.2024.109929. PMID: 38799566; PMCID: PMC11126816.
Bellon N, Bataille P, Bonigen J, Charbit-Henrion F, Dietrich C, Polivka L, Hadj-Rabia S, Leite de Moraes M, Bodemer C. Experience of dupilumab treatment in inherited epidermolysis bullosa: a short series. J Am Acad Dermatol. 2024; Apr 26:S0190-9622(24)00655-8. doi: 10.1016/j.jaad.2024.04.037. PMID: 38679237.
Rytter H, Roger K, Chhuon C, Ding X, Coureuil M, Jamet A, Henry T, Guerrera IC, Charbit A. Dual proteomics of infected macrophages reveal bacterial and host players involved in the Francisella intracellular life cycle and cell to cell dissemination by merocytophagy. Sci Rep. 2024; Apr 2;14(1):7797. doi: 10.1038/s41598-024-58261-x. PMID: 38565565; PMCID: PMC10987565.
Herder C, Roden M, Venteclef N. Diabetes and pulmonary infection: how hyperglycaemia shapes the immune system. Signal Transduct Target Ther. 2024; Mar 13;9(1):67. doi: 10.1038/s41392-024-01784-6. PMID: 38480708.
Lezmi G, Poirault C, Grauso M, Dietrich C, Adel-Patient K, Leite-de-Moraes M. Identification of the major immune differences in severe asthmatic children according to their atopic dermatitis status. Cell Immunol. 2024; Feb 27;397-398:104815. doi: 10.1016/j.cellimm.2024.104815. PMID: 38428350.